logo
  

ACADIA Pharmaceuticals Inc. (ACAD) Soared To An All-Time High On Speculation

ACADIA Pharmaceuticals Inc. (ACAD) climbed steadily until around mid-afternoon Tuesday, but settled into a range going into the close. Shares finished with a gain of 6.95 at $45.88 on the highest volume of the year.

ACADIA Pharmaceuticals soared to an all-time high Tuesday. The company recently canceled two investor meetings, which fueled speculation that the company may be working on a deal to sell itself.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
RELATED NEWS
Follow RTT